NAD+ Therapy

NAD+ Therapy For Women

Cellular Restoration Through Coenzyme Science

NAD+ is the coenzyme your cells require for every metabolic transaction that sustains life — from mitochondrial energy production to DNA damage repair. Between the ages of 40 and 60, circulating NAD+ levels decline by approximately 50 percent. For women navigating hormonal transitions, this decline accelerates. The metabolic demands of perimenopause and menopause consume NAD+ reserves at a rate that outpaces natural replenishment, producing a compounding deficit that manifests as cognitive dulling, persistent fatigue, accelerated skin aging, and a systemic erosion of cellular resilience.

Kassy Wellness delivers physician-supervised NAD+ IV infusions to your Orlando home, restoring coenzyme architecture at the cellular level and rebuilding the metabolic foundation that hormonal transition disrupts.

Initialize Consultation Women's NAD+ Protocol
Women's NAD+ IV therapy in Orlando — cellular restoration and anti-aging infusions for women at Kassy Wellness
PROTOCOL STATUS Physician-Supervised
RECOGNITION

Why NAD+ Matters For Women

You notice it in the margins first. The word that used to arrive instantly now takes a beat to surface. The mental throughput that powered your most complex decisions softens almost imperceptibly. Your skin, once luminous without effort, begins losing the cellular vitality that no topical serum can restore. Workouts that once produced visible results now yield diminishing returns. Recovery from illness, travel, or stress stretches longer than it should. You begin to feel older than your age — not in some vague psychological sense, but at a biological level you can sense in your tissues, your cognition, and your energy reserves.

These are not symptoms of aging in the way conventional medicine frames them. They are symptoms of NAD+ depletion — a measurable, correctable deficit in the coenzyme that drives over 500 enzymatic reactions in human cells. NAD+ (nicotinamide adenine dinucleotide) is required for mitochondrial ATP synthesis, sirtuin activation, PARP-mediated DNA repair, circadian rhythm regulation, and the inflammatory resolution pathways that maintain cellular homeostasis. When NAD+ levels fall, every one of these systems degrades simultaneously.

The decline is not linear, and it is not gender-neutral. Research demonstrates that NAD+ concentrations decrease by approximately 50 percent between ages 40 and 60 across the general population. But women experience an accelerated depletion curve during perimenopause and menopause. The hormonal shifts that characterize these transitions — fluctuating estrogen, declining progesterone, increased cortisol output — place extraordinary metabolic demand on NAD+-dependent pathways. Estrogen metabolism itself requires NAD+ as a cofactor. Inflammatory cascades triggered by hormonal instability consume NAD+ reserves that would otherwise support DNA repair and mitochondrial function. The result is a compounding deficit: hormonal transition depletes NAD+, and NAD+ depletion amplifies the symptoms of hormonal transition.

This is not a problem that resolves with more sleep, better supplements, or reduced stress. It is a coenzyme deficit that requires direct cellular restoration — restoring the molecular substrate that every other system in your body depends upon to function at its designed capacity.

METHODOLOGY

How NAD+ IV Therapy Works

Oral NAD+ precursors — NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — have generated significant interest in longevity research. However, oral delivery faces a fundamental pharmacokinetic limitation: gastrointestinal degradation and hepatic first-pass metabolism reduce bioavailability to a fraction of the ingested dose. The NAD+ that reaches your cells after oral supplementation represents a substantially diminished quantity compared to what entered your digestive system. For women with clinically significant NAD+ depletion, this incremental approach may fail to overcome the threshold required for meaningful cellular restoration.

Intravenous NAD+ delivery bypasses the gastrointestinal tract entirely, providing 100 percent bioavailability directly to the bloodstream. The coenzyme reaches every tissue, every mitochondrion, and every nuclear compartment at therapeutic concentrations that oral supplementation cannot achieve. This is not a subtle distinction — it is the difference between resupplying a depleted reservoir through a narrow channel and refilling it directly at the source.

The infusion protocol is administered over two to four hours in the comfort of your home, under direct physician supervision. The extended infusion duration is deliberate: NAD+ must be delivered at a controlled rate to minimize transient flushing and allow cellular uptake to proceed at optimal kinetics. During the infusion, NAD+ enters your cells and immediately begins activating sirtuins (SIRT1 through SIRT7) — the family of proteins responsible for gene expression regulation, mitochondrial biogenesis, inflammation modulation, and epigenetic maintenance. Simultaneously, NAD+ replenishes the substrate pool for PARP enzymes (poly ADP-ribose polymerases), which detect and repair single-strand DNA breaks that accumulate with age and oxidative stress. At the mitochondrial level, restored NAD+ concentrations recover electron transport chain efficiency and membrane potential, directly increasing cellular ATP output — the molecular currency of energy that powers every biological process.

PROTOCOL ARCHITECTURE

The Women'S NAD+ Protocol

Phase I

Cellular Assessment

Your NAD+ restoration begins with diagnostic precision. We evaluate your baseline NAD+ status alongside metabolic markers, oxidative stress indicators, and a comprehensive hormone panel — because NAD+ requirements increase significantly during hormonal transition, and your protocol must account for this interdependence.

Deliverables

  • NAD+ baseline evaluation
  • Metabolic marker profiling
  • Oxidative stress assessment
  • Hormone panel integration
  • Physician review and protocol design
Phase II

NAD+ Infusion Series

Your loading dose protocol is titrated specifically for female physiology, accounting for body composition, hormonal status, and metabolic demand. Each infusion is paired with glutathione and B-complex cofactors to enhance cellular uptake and maximize the downstream activation of sirtuin and PARP pathways.

Deliverables

  • NAD+ loading dose protocol
  • Titration for female physiology
  • Glutathione co-infusion
  • B-complex cofactor pairing
  • Physician-monitored at-home delivery
Phase III

Maintenance & Integration

Sustained cellular resilience requires ongoing coenzyme replenishment. Monthly maintenance infusions preserve the NAD+ levels established during your loading series, while integration with hormone optimization protocols creates a comprehensive anti-aging and energy architecture that evolves with your biology.

Deliverables

  • Monthly maintenance infusions
  • Hormone protocol integration
  • Cognitive performance tracking
  • Ongoing physician access
  • Protocol refinement at intervals
CELLULAR RESILIENCE

Benefits For Women

Cognitive Clarity & Neuroprotection

NAD+ fuels sirtuin-mediated neuroprotection and supports synaptic plasticity, neurotransmitter synthesis, and cerebrovascular perfusion. Restored coenzyme levels rebuild the cognitive throughput that NAD+ depletion erodes — sharper recall, faster processing, and sustained executive function.

Anti-Aging At The Cellular Level

PARP enzyme activation repairs accumulated DNA damage while sirtuin-driven epigenetic maintenance preserves telomere integrity and chromosomal stability. NAD+ restoration addresses aging at its molecular origin — not its cosmetic surface — producing measurable improvements in biological age markers.

Enhanced Mitochondrial Energy

Restored NAD+ concentrations recover electron transport chain efficiency and mitochondrial membrane potential, directly increasing ATP synthesis. The result is consistent, sustained energy production at the cellular level — eliminating the fatigue cycles that characterize coenzyme depletion.

Hormonal Transition Support

NAD+ serves as a critical cofactor for estrogen metabolism, thyroid enzyme function, and adrenal cortisol regulation. Replenishing NAD+ during perimenopause and menopause provides the metabolic resilience these transitions demand, reducing the systemic burden of hormonal recalibration.

SYNERGY

NAD+ And Hormonal Health

The relationship between NAD+ and hormonal health is not peripheral — it is foundational. NAD+ serves as a required cofactor for the enzymatic pathways that metabolize estrogen, synthesize thyroid hormones, and regulate the hypothalamic-pituitary-adrenal axis that governs cortisol output. When NAD+ reserves are depleted, these pathways lose efficiency. Estrogen metabolites accumulate rather than clearing through proper detoxification channels. Thyroid conversion from T4 to active T3 slows. Adrenal output becomes dysregulated, producing the cortisol irregularities that fragment sleep, destabilize mood, and accelerate visceral fat deposition.

During perimenopause and menopause, these demands intensify. The metabolic cost of navigating hormonal transition consumes NAD+ at an accelerated rate, creating a deficit that amplifies the very symptoms the transition produces. Fatigue deepens. Cognitive clarity diminishes further. Inflammatory markers rise as the resolution pathways that depend on NAD+ lose their substrate. This is not a single-variable problem — it is a cascade where coenzyme depletion and hormonal instability reinforce each other in a compounding loop.

Combining NAD+ restoration with bioidentical hormone optimization creates a comprehensive cellular resilience architecture that addresses both the coenzyme substrate and the endocrine signaling that depends on it. NAD+ provides the metabolic foundation. Hormone optimization provides the regulatory framework. Together, they restore the integrated biological system that sustains energy, cognition, and vitality across the hormonal lifespan.

Reviewed by Dr. Manganello, Medical Director — Board-certified in regenerative medicine with clinical focus on NAD+ therapeutics and women's cellular health. Learn more
GREATER ORLANDO

Areas We Serve

COMMON QUESTIONS

NAD+ coenzyme science for women, simplified.

NAD+ Therapy FAQ

Q

What Does An NAD+ Infusion Feel Like?

A

Most women describe the experience as deeply restorative. You may feel a warm flushing sensation, mild chest tightness, or light nausea during the first 15 to 30 minutes as your body acclimates to the infusion rate — these are transient and resolve quickly as the rate is titrated to your comfort. Many patients read, work on a laptop, or rest during the two-to-four-hour session. As the infusion progresses, most women report increasing clarity, calm energy, and a sense of mental sharpness. By the end of the session, the predominant sensation is one of restored vitality — as though your cells have been recharged at a foundational level. Side effects are rare and mild when the infusion is administered at the appropriate rate under physician supervision.

Schedule your consultation
Q

How Often Should Women Receive NAD+ Therapy?

A

The optimal frequency depends on your baseline NAD+ status, metabolic demand, and therapeutic goals. Most women begin with a loading series of three to five infusions over a two-week period to establish therapeutic coenzyme levels. Following the loading phase, monthly maintenance infusions sustain the NAD+ concentrations required for ongoing sirtuin activation, DNA repair, and mitochondrial function. Women navigating active hormonal transitions — perimenopause, menopause, or post-surgical recovery — may benefit from more frequent sessions during the transition period. Your physician designs your schedule based on diagnostic data and adjusts it as your biology responds.

Q

Is NAD+ Therapy Safe During Perimenopause?

A

NAD+ is an endogenous coenzyme — it is a molecule your body already produces and requires for survival. Intravenous NAD+ therapy replenishes a naturally declining substrate rather than introducing a foreign substance. For perimenopausal women, NAD+ restoration is particularly relevant because the metabolic demands of hormonal transition actively deplete NAD+ reserves. When administered under physician supervision with appropriate diagnostic evaluation, NAD+ IV therapy maintains a favorable safety profile during perimenopause. At Kassy Wellness, Dr. Manganello evaluates your complete hormonal and metabolic status before initiating NAD+ therapy, ensuring the protocol is calibrated to your specific physiology and any concurrent treatments you may be receiving.

Begin your perimenopause assessment
Q

How Does NAD+ IV Compare To Oral NMN Supplements?

A

Oral NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors that must survive gastrointestinal degradation, be absorbed through the intestinal lining, and undergo hepatic conversion before reaching systemic circulation as NAD+. This multi-step process results in significantly reduced bioavailability — only a fraction of the ingested dose reaches your cells as usable NAD+. Intravenous NAD+ bypasses the entire gastrointestinal pathway, delivering 100 percent of the therapeutic dose directly to the bloodstream at concentrations that oral supplementation cannot achieve. For women with clinically significant NAD+ depletion, the difference between incremental precursor supplementation and direct coenzyme restoration determines whether the therapeutic threshold for meaningful cellular repair is reached.

Q

When Will I Notice Results From NAD+ Therapy?

A

Many women report noticeable improvements in mental clarity and energy within 24 to 48 hours following their first infusion. The cognitive sharpness and sustained focus often described as the hallmark of NAD+ restoration typically consolidate over the first three to five sessions of the loading series. Improvements in sleep quality, skin vitality, and exercise recovery develop progressively over four to eight weeks as cellular repair mechanisms reach full activation. The most profound and sustained results emerge during the maintenance phase, when consistent NAD+ levels support ongoing sirtuin activity, mitochondrial biogenesis, and DNA repair. Your physician tracks both subjective and objective markers throughout your protocol to document your biological response.

Meet our Medical Director
Q

Can NAD+ Therapy Be Combined With Hormone Optimization?

A

Not only can they be combined — they are designed to complement each other. NAD+ provides the coenzyme substrate that hormone metabolic pathways require for efficient function. Hormone optimization provides the endocrine signaling framework that directs how cellular energy and repair resources are allocated. When NAD+ levels are depleted, even optimally dosed bioidentical hormones operate on a diminished metabolic foundation. And when hormonal architecture is unstable, NAD+ reserves are consumed at an accelerated rate. The integrated approach addresses both dimensions of cellular health simultaneously, creating a resilience architecture that neither therapy achieves independently. Your physician coordinates both protocols to maximize synergistic benefit.

More questions? Schedule a consultation
INVESTMENT

$8,000 $12,000

Your complete NAD+ restoration protocol. Cellular assessment, physician-supervised infusion series, glutathione and B-complex pairing, and ongoing maintenance access included.

Initialize Your Consultation

The information provided on this page is for educational purposes only and is not intended as medical advice. NAD+ IV therapy is a medical treatment that requires physician supervision, diagnostic evaluation, and ongoing clinical monitoring. Individual results vary based on biological factors, protocol compliance, and treatment duration. All treatments at Kassy Wellness are prescribed and supervised by licensed physicians. This content has been reviewed by our Medical Director for clinical accuracy. Kassy Wellness does not guarantee specific outcomes. Please consult with a qualified healthcare provider before beginning any NAD+ therapy protocol.